ClinicalTrials.Veeva

Menu

European Registry of Patients With Infantile-onset Spinal Muscular Atrophy

I

Institut de Myologie, France

Status

Completed

Conditions

Spinal Muscular Atrophy

Study type

Observational

Funder types

Other

Identifiers

NCT03339830
IO-SMA-Registry
2017-A02291-52 (Other Identifier)

Details and patient eligibility

About

IO-SMA-Registry is a prospective, longitudinal and observational study which objective is to collect prospectively information on longevity, psychomotor development and respiratory function of patients with infantile-onset spinal muscular atrophy.

Enrollment

100 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Spinal Muscular Atrophy diagnosed in childhood (before 18 months) and genetically confirmed.
  • For patients with SMA type 1: Never acquired independent sitting position (more than 30 seconds, without hand support or any external support)
  • For patients with SMA type 2 or 3: Patient treated with a market approved treatment for SMA or with a treatment in an expanded access program
  • Any age
  • Patients over 18 years of age or parent(s)/legal guardian(s) of patients < 18 years of age not opposed to data collection for research purposes

Exclusion criteria

  • None

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems